Page last updated: 2024-11-05

n-nitrosoperhydroazepine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID13613
CHEMBL ID165191
SCHEMBL ID1578024
MeSH IDM0043453

Synonyms (33)

Synonym
932-83-2
1-nitrosoazepane
nitrosohexamethylenimine
1h-azepine, hexahydro-1-nitroso-
einecs 213-258-6
n-nitrosohexahydroazepine
brn 1237798
n-nitrosohexamethylenimine
n-6-mi
hexahydro-1-nitroso-1h-azepine
n-nitrosoazacycloheptane
n-nitrosoperhydroazepine
ccris 468
n-nitrosohexamethyleneimine
FT-0693742
1-nitroso-azepane
CHEMBL165191
AKOS006271678
n67x53n3yt ,
5-20-04-00067 (beilstein handbook reference)
unii-n67x53n3yt
dtxcid301040
NCGC00256532-01
tox21_302820
cas-932-83-2
dtxsid0021040 ,
SCHEMBL1578024
UZMVSVHUTOAPTD-UHFFFAOYSA-N
nitrosohexamethyleneimine, n-
hexahydro-1-nitrosoazepine
D93582
AS-76918
EN300-1296525

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Survival was better in SENCAR mice dosed with NHEX than in the other 2 strains."( Strain comparison of systemic N-nitrosohexamethyleneimine carcinogenesis in BALB/c, SENCAR and CD-1 mice.
Kovatch, RM; Lijinsky, W; Strickland, PT; Thomas, B, 1988
)
0.27
"A method is described for the determination of N-nitrosohexamethyleneimine, a potential carcinogen, in tolazamide bulk drug and pharmaceutical dosage forms."( Monitoring a potential carcinogen in pharmaceutical formulations at the low part per billion level. High-performance liquid chromatographic determination of N-nitrosohexamethyleneimine in tolazamide.
Severin, G, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (93.33)18.7374
1990's1 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]